Benedetto Grimaldi

Has grant

Senior Researcher

Istituto Italiano di Tecnologia
Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Therapeutic clock

Open Date: 2013-02-01

Close Date: 2015-02-01

Grant: Close

Circadian nuclear receptor REV-ERBbeta and autophagy: metabolic and molecular links for novel anticancer combined strategy

Open Date:

Close Date:

Articles (4)

Year:

2026

Year:

2024

Year:

2024

Background EZH2 promotes aggressive-variant prostate cancer (AVPC) progression via histone H3-Lysine-27 tri-methylation (H3K27me3). We hypothesize that epigenetic reprogramming via EZH2 inhibitors (EZH2i) improves the efficacy of chemotherapy in AVPC. Methods We studied the expression of EZH2 in clinical prostate cancer cohorts (bioinformatics). We determined the effect of EZH2i on both cellular- and cell-free-H3K27me3 levels. We measured effects of carboplatin with/without EZH2i on AVPC cell viability (IC 50 ). We studied how EZH2i modulate gene expression (RNA Seq). Results EZH2 was significantly up-regulated in AVPC vs other prostate cancer types. EZH2i reduced both cellular and cell free-H3K27me3 levels. EZH2i significantly reduced carboplatin IC 50 . EZH2i reduced the expression of DNA repair and increased the expression of pro-apoptotic genes. Article Highlights Polycomb-mediated gene silencing promotes prostate cancer progression Aggressive-variant prostate cancers (AVPCs) are characterized by increased activity of the Polycomb-Repressive Complex 2 (PRC2) Here we show that PRC2 inhibitors are scarcely effective as monotherapy in ACPC cells However the combination of PRC2 inhibitors and carboplatin is highly synergistic RNA Seq studies revealed that PRC2 inhibitors enhance carboplatin activity by modulating several key pathways, including DNA repair and apoptosis.

Year:

2024

Collaborators (6)

Shusuke Akamatsu

Professor

Nagoya University Hospital

JAPAN
View details

Marc Panosetti

Non-Stipendiary Lecturer in Organic Chemistry

University of Oxford

UNITED KINGDOM
View details

Sushila Rigas

Open University

UNITED KINGDOM
View details

Elena Jachetti

Researcher (non-academic)

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

Francesco Crea

Professor (Chair) of Cancer Pharmacology

Open University

UNITED KINGDOM
View details

Maria Duca

Université Côte d'Azur

FRANCE
View details